Leading neurologists at the Lalitha CME Series in Guntur have highlighted a concerning rise in peripheral neuropathy, particularly among the elderly and diabetic patients. The conference emphasized the urgent need for early diagnosis using advanced imaging and systemic management.
- Peripheral neuropathy affects 1% of the general population and 10% of adults over 60.
- Diabetes is a primary driver, contributing to approximately 50% of all neuropathy cases.
- New disorders like nodopathies and paranodopathies are causing rapid limb weakness and tremors.
- Advanced diagnostics such as MR Neurography and nerve ultrasound are revolutionizing detection.
In a critical gathering of medical minds, the Lalitha PVS Institute of Medical Sciences hosted the Lalitha CME Series on ‘Advances in Peripheral Neuropathy’ in Guntur. The event brought together approximately 200 doctors, neurologists, and academic faculty from across Andhra Pradesh and Telangana to address the growing burden of nerve disorders in the Indian population.
Dr. Satish Khadilkar of Bombay Hospital, Mumbai, opened the session by introducing the medical community to emerging nerve disorders known as nodopathies and paranodopathies. These specific conditions are particularly dangerous as they can lead to rapid weakness in all four limbs, gait unsteadiness, and tremors. He emphasized that the integration of MR Neurography and nerve ultrasound is now essential for visualizing affected nerves and ensuring accurate diagnosis.
The scale of the issue was further quantified by P. Vijaya, Managing Director and HOD of Neurosciences, who revealed that while the general prevalence is 1%, the risk jumps tenfold for those over the age of 60. A staggering 50% of these cases are linked to diabetes, highlighting a systemic failure in the early recognition of diabetic complications in India.
Why This Matters
BozokMedia analysis shows that the intersection of an aging population and the diabetes epidemic in India is creating a 'silent crisis' of nerve damage. When neuropathy goes undetected, it leads to permanent disability and a significant loss of quality of life. The shift toward neuromodulation, such as spinal cord stimulation, indicates a transition from mere symptom management to advanced therapeutic intervention.
Early recognition and a systematic approach to evaluation are the only ways to prevent permanent disability in neuropathy patients.
Adding to the clinical discourse, R. Muralidhar Reddy from Hyderabad stressed that prevention is rooted in aggressive lifestyle management. He argued that strict glycemic control, management of hypertension, obesity, and cholesterol, combined with regular exercise, are the first lines of defense against diabetic neuropathy.
The conference also touched upon the evolving landscape of infectious diseases. Madhu Nagappa from NIMHANS discussed the alarming link between infectious neuropathies and modern viral threats, specifically citing COVID-19, Zika, and enteroviruses as potential triggers for nerve damage.
| Factor | General Population | Seniors (60+) |
|---|---|---|
| Prevalence Rate | ~1% | ~10% |
| Primary Trigger | Various/Genetic | Diabetes/Age-related |
| Risk Level | Low to Moderate | High |
Frequently Asked Questions
Q1: What are the primary symptoms of peripheral neuropathy?
Symptoms typically include numbness, tingling, weakness, or pain in the hands and feet, and in severe cases, it can lead to loss of balance and tremors.
Q2: How can one prevent diabetic neuropathy?
Prevention requires a combination of strict blood sugar control, maintaining a healthy weight, managing blood pressure and cholesterol, and staying physically active.
